In The Media
Learn about PALADIN’s mission to transform the pace of medicines development through collaboration between patient advocacy groups and pharmaceutical companies.
CSL is a member of PALADIN, a one-of-a-kind consortium that’s bringing together industry leaders and patient advocacy groups. Get a peek inside the playbook created together to guide partnerships.
In this interview, Vicky DiBiaso, Global Head, Patient Informed Development & Health Value Translation at Sanofi and Kenneth Getz, Executive Director/Professor, Tufts CSDD and Founder/Board Chair, CISCRP, discuss the formation, mission and goals for PALADIN.
In the spring of 2023, Sanofi provided thought leadership and funding to launch a pre-competitive, disease-agnostic Consortium whose mission is to optimize advocacy group-industry collaboration to ultimately accelerate the pace of medicines development.
First-of-its-kind consortium brings together advocacy and industry organizations to address efficiencies across disease types that have the potential to speed the development of medicines for patients.